文献速递免疫规划慢病防控与筛查

HPV疫苗接种与慢性疲劳综合征/肌痛性脑脊髓炎风险:挪威全国登记研究

HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway.
PubMed 文献 · Vaccine · 2017-06-23

研究链接挪威多国家登记库数据,分析2009—2014年10—17岁人群CFS/ME年发病率,并对176,453名1997—2002年出生、符合HPV疫苗接种条件的女孩评估接种与CFS/ME风险。结果显示HPV疫苗接种与CFS/ME风险无关联(全程HR=0.86,95%CI 0.69—1.08),既往住院接触越多CFS/ME风险越高且接种率越低。

要点

  • 女孩与男孩CFS/ME年发病率上升幅度相似,IRR分别为1.15(95%CI 1.10—1.19)和1.15(95%CI 1.09—1.22)。
  • HPV疫苗接种与CFS/ME风险无关联,全程HR=0.86(95%CI 0.69—1.08),接种后前两年HR=0.96(95%CI 0.64—1.43)。
  • 既往住院接触7次及以上者较无接触者CFS/ME风险升高,HR=5.23(95%CI 3.66—7.49)。

核心结论

  • 在挪威通过国家免疫规划首批接种HPV疫苗的6个出生队列女孩中,未观察到HPV疫苗接种后CFS/ME风险升高的迹象。

研究设计与样本

  • 基于挪威人口登记库、挪威患者登记库和挪威免疫登记库的全国登记研究,通过个人识别号链接个体数据。
  • 计算2009—2014年居住在挪威的824,133名10—17岁男孩和女孩的CFS/ME年发病率。
  • 纳入176,453名1997—2002年出生、符合HPV疫苗接种条件的女孩进行进一步分析,采用Cox回归估计CFS/ME的风险比(HR),采用二项回归估计接种率的风险差(RD)。

主要发现

  • 女孩和男孩CFS/ME年发病率均逐年上升,女孩IRR=1.15(95%CI 1.10—1.19),男孩IRR=1.15(95%CI 1.09—1.22)。
  • HPV疫苗接种与CFS/ME无关联,整个随访期HR=0.86(95%CI 0.69—1.08),接种后前两年HR=0.96(95%CI 0.64—1.43)。
  • 既往住院接触次数越多,CFS/ME风险越高,7次及以上接触者较无接触者HR=5.23(95%CI 3.66—7.49)。
  • 有7次及以上住院接触的女孩较无既往住院接触的女孩更少接种疫苗,RD=-5.5%(95%CI -6.7%至-4.2%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccination has been suggested to be involved in the aetiology of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). HPV vaccine was introduced in the Norwegian Childhood Immunisation Programme and offered 12year old girls from 2009. We studied the association between HPV vaccination and risk of CFS/ME and also assessed medical history in relation to both risk of CFS/ME and HPV vaccine uptake. METHODS: Individual data from national registries, including the Norwegian Population Registry, the Norwegian Patient Registry and the Norwegian Immunisation Registry were linked using the unique personal identification number. Yearly incidence rates of CFS/ME for 2009-2014 were calculated among the 824,133 boys and girls, aged 10-17 living in Norway during these 6years. A total of 176,453 girls born 1997-2002 were eligible for HPV vaccination and included in further analyses. Hazard ratios (HRs) of CFS/ME were estimated using Cox regression. Risk differences (RDs) of vaccine uptake were estimated with binomial regression. RESULTS: A similar yearly increase in incidence rate of CFS/ME was observed among girls and boys, IRR=1.15 (95% confidence interval (CI) 1.10-1.19) and 1.15 (95% CI 1.09-1.22), respectively. HPV vaccination was not associated with CFS/ME, HR=0.86 (95% CI 0.69-1.08) for the entire follow-up period and 0.96 (95% CI 0.64-1.43) for the first two years after vaccination. The risk of CFS/ME increased with increasing number of previous hospital contacts, HR=5.23 (95% CI 3.66-7.49) for 7 or more contacts as compared to no contacts. Girls with 7 or more hospital contacts were less likely to be vaccinated than girls with no previous hospital contacts, RD=-5.5% (95% CI -6.7% to -4.2%). CONCLUSIONS: No indication of increased risk of CFS/ME following HPV vaccination was observed among girls in the first 6 birth cohorts offered HPV vaccine through the national immunisation programme in Norway.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Feiring B, Laake I, Bakken IJ, et al. HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway. Vaccine. 2017. PMID: 28648542. doi:10.1016/j.vaccine.2017.06.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。